A comprehensive review on wedelolactone: natural sources, total synthesis, and pharmacological activities.
10.1016/S1875-5364(25)60821-1
- Author:
Haiping CAI
1
;
Yue WU
1
;
Xiaojin ZHANG
2
Author Information
1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China.
2. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China. Electronic address: zxj@cpu.edu.cn.
- Publication Type:Review
- Keywords:
Mechanism;
Natural product;
Pharmacological activity;
Synthesis;
Wedelolactone
- MeSH:
Coumarins/isolation & purification*;
Humans;
Animals;
Biological Products/chemical synthesis*;
Molecular Structure;
Plant Extracts/chemical synthesis*;
Wedelia/chemistry*;
Eclipta/chemistry*
- From:
Chinese Journal of Natural Medicines (English Ed.)
2025;23(2):169-181
- CountryChina
- Language:English
-
Abstract:
Plant-derived natural products have long been a vital source for developing therapeutic drugs. Wedelolactone (WDL), a coumestan isolated from Eclipta prostrata, Wedelia calendulacea, Wedelia chinensis, and Sphagneticola trilobata, demonstrates a broad spectrum of therapeutic potential, including anticancer, anti-inflammatory, anti-obesity, anti-myotoxic, antimicrobial, anti-diabetic, and tissue-protective activities. This review synthesizes information on the isolation, total synthesis, pharmacological activity, underlying mechanisms, and pharmacokinetic properties of WDL. Additionally, it offers insights into potential clinical applications and future drug discovery avenues utilizing WDL or its derivatives, either independently or in combination with other pharmaceuticals.
